仟源医药
(300254)
| 流通市值：19.71亿 | | | 总市值：22.30亿 |
| 流通股本：2.27亿 | | | 总股本：2.57亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 351,884,456.08 | 173,800,715.3 | 870,786,344.11 | 611,473,385.33 |
| 营业总成本 | 340,846,294.47 | 170,452,586.99 | 784,341,269.05 | 552,167,468.27 |
| 其他经营收益 | | | | |
| 营业利润 | 9,831,530.47 | 5,705,370.75 | 79,775,771.77 | 70,853,872.88 |
| 利润总额 | 19,193,043.41 | 13,388,829.51 | 90,793,835.16 | 77,369,333.81 |
| 净利润 | 11,718,213.71 | 7,966,764.9 | 56,437,313.63 | 48,470,797.18 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 11,718,213.71 | 7,966,764.9 | 56,437,313.63 | 48,470,797.18 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 518,288,533.16 | 563,644,604.25 | 604,059,057.16 | 517,950,557.72 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,010,439,551.56 | 1,024,775,870.22 | 1,038,531,371.55 | 1,031,814,800.4 |
| 资产总计 | 1,528,728,084.72 | 1,588,420,474.47 | 1,642,590,428.71 | 1,549,765,358.12 |
| 流动负债: | | | | |
| 流动负债合计 | 519,797,267.83 | 572,410,897.31 | 617,206,136.63 | 565,452,331.03 |
| 非流动负债: | | | | |
| 非流动负债合计 | 481,916,552.02 | 501,938,084.77 | 431,058,920.22 | 407,220,676.58 |
| 负债合计 | 1,001,713,819.85 | 1,074,348,982.08 | 1,048,265,056.85 | 972,673,007.61 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 449,712,469.35 | 440,252,038.33 | 304,621,392.23 | 294,207,395.41 |
| 股东权益合计 | 527,014,264.87 | 514,071,492.39 | 594,325,371.86 | 577,092,350.51 |
| 负债和股东权益合计 | 1,528,728,084.72 | 1,588,420,474.47 | 1,642,590,428.71 | 1,549,765,358.12 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 435,359,243.54 | 222,260,887.48 | 833,831,039.4 | 585,903,335.94 |
| 经营活动现金流出小计 | 354,285,184.02 | 201,157,459.55 | 737,063,167.17 | 510,491,482.08 |
| 经营活动产生的现金流量净额 | 81,074,059.52 | 21,103,427.93 | 96,767,872.23 | 75,411,853.86 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,451,438.23 | 1,815,454.43 | 2,713,013.01 | 121,979 |
| 投资活动现金流出小计 | 26,841,026.9 | 155,465,765.54 | 94,604,279.88 | 88,932,494.7 |
| 投资活动产生的现金流量净额 | -25,389,588.67 | -153,650,311.11 | -91,891,266.87 | -88,810,515.7 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 217,020,000 | 177,500,000 | 331,260,000 | 242,760,000 |
| 筹资活动现金流出小计 | 337,249,933.14 | 68,663,070.4 | 324,331,821.64 | 249,903,546.24 |
| 筹资活动产生的现金流量净额 | -120,229,933.14 | 108,836,929.6 | 6,928,178.36 | -7,143,546.24 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -64,545,462.29 | -23,709,953.58 | 11,804,783.72 | -20,542,208.08 |
| 期末现金及现金等价物余额 | 96,766,362.39 | 137,601,871.1 | 161,311,824.68 | 128,964,832.88 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -64,545,462.29 | - | 11,804,783.72 | - |